Literature DB >> 21160976

ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line.

Yuriy K Bashmakov1, Nailia A Zigangirova, Alexander L Gintzburg, Petr A Bortsov, Ivan M Petyaev.   

Abstract

AIM: To evaluate the direct binding of two main chlamydial biovars (C. trachomatis and C. pneumoniae) to plasma lipoproteins and its effect on chlamydial infection rate in human hepatoma cell line (HepG2 cells).
METHODS: Murine plasma lipoproteins were fractionated and isolated using fast-performance liquid chromatography (FPLC), spotted on nitrocellulose membrane and incubated with chlamydial suspensions. Direct binding of chlamydial particles to lipoprotein fractions has been studied using lipopolysaccharide-specific antibodies in immuno-dot blot binding assay and immunoprecipitation analysis. Immunostaining protocol as well as flow cytometry analysis have been employed to study the infectivity rate of chlamydial species in HepG2 cells.
RESULTS: Elementary bodies of both C. trachomatis and C. pneumoniae bind ApoB-containing fractions of plasma lipoproteins. That binding becomes stronger when heat-denatured FPLC fractions are used, suggesting a primary role of apolipoproteins in interaction between chlamydial particle and lipoprotein. Both chlamydial biovars efficiently propagate in human hepatoma cell line - HepG2 cells even in serum free conditions forming late-stage inclusion bodies and releasing extracellular elementary bodies. Preincubation of C. trachomatis and C. pneumoniae with native ApoB-containing lipoproteins enhances the rate of chlamydial infection in HepG2 cells.
CONCLUSION: A productive infection caused by C. trachomatis and C. pneumoniae may take place in human-derived hepatocytes revealing hepatic cells as possible target in chlamydial infection. Obtained results may suggest the participation of lipoprotein receptors in the mechanism of attachment and/or entry of chlamydial particles into target cells.

Entities:  

Keywords:  ApoB-containing lipoproteins; Chlamydial pneumoniae; Chlamydial trachomatis; Human hepatoma cell line; Liver infection

Year:  2010        PMID: 21160976      PMCID: PMC2999269          DOI: 10.4254/wjh.v2.i2.74

Source DB:  PubMed          Journal:  World J Hepatol


  20 in total

1.  A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples.

Authors:  D W Garber; K R Kulkarni; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

Review 2.  Chlamydia--host cell interactions: recent advances on bacterial entry and intracellular development.

Authors:  Alice Dautry-Varsat; María Eugenia Balañá; Benjamin Wyplosz
Journal:  Traffic       Date:  2004-08       Impact factor: 6.215

3.  Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis.

Authors:  Jimmy F P Berbée; Caroline C van der Hoogt; Robert Kleemann; Emile F Schippers; Richard L Kitchens; Jaap T van Dissel; Irma A J M Bakker-Woudenberg; Louis M Havekes; Patrick C N Rensen
Journal:  FASEB J       Date:  2006-08-25       Impact factor: 5.191

4.  Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells.

Authors:  Mirja Puolakkainen; Cho-Chou Kuo; Lee Ann Campbell
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.

Authors:  Fei Cao; Antonio Castrillo; Peter Tontonoz; Fabio Re; Gerald I Byrne
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

6.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.

Authors:  Shirya Rashid; David E Curtis; Rita Garuti; Norma N Anderson; Yuriy Bashmakov; Y K Ho; Robert E Hammer; Young-Ah Moon; Jay D Horton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

Review 7.  Hepatitis C virus particles and lipoprotein metabolism.

Authors:  Patrice André; Gabriel Perlemuter; Agata Budkowska; Christian Bréchot; Vincent Lotteau
Journal:  Semin Liver Dis       Date:  2005-02       Impact factor: 6.115

8.  [The immunochemical and biological properties of monoclonal antibodies to Chlamydia trachomatis].

Authors:  A V Kutlin; E I Drobyshevskaia; A A Shatkin
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1996 Jan-Feb

9.  Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2.

Authors:  Guqi Wang; Frank Burczynski; Judy Anderson; Guangming Zhong
Journal:  Microbiology (Reading)       Date:  2007-06       Impact factor: 2.777

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  3 in total

1.  Lipids: a key player in the battle between the host and microorganisms.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2012-10-17       Impact factor: 5.922

2.  Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics.

Authors:  Jeroen van Bergenhenegouwen; Aletta D Kraneveld; Lieke Rutten; Johan Garssen; Arjan P Vos; Anita Hartog
Journal:  BMC Immunol       Date:  2016-10-28       Impact factor: 3.615

3.  Infection, disease, and transmission dynamics in calves after experimental and natural challenge with a Bovine Chlamydia psittaci isolate.

Authors:  Carola Ostermann; Anke Rüttger; Evelyn Schubert; Wieland Schrödl; Konrad Sachse; Petra Reinhold
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.